Bacteria Are New Targets for Inhibitors of Human Farnesyltransferase
Farnesyltransferase inhibitors (FTIs) are focus for the treatment of several diseases, particularly in the field of cancer therapy. Their potential, however, goes even further, as a number of studies have evaluated FTIs for the treatment of infectious diseases such as malaria, African sleeping sickn...
Guardado en:
Autores principales: | Lea Weber, Anna Hagemann, Jila Kaltenhäuser, Manuela Besser, Patrick Rockenfeller, Anja Ehrhardt, Ewa Stuermer, Hagen Sjard Bachmann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a3e8589be9a54fd8be8389b29ac75ab9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Modelado de las Relaciones Cuantitativas Estructura-Actividad (QSAR) de Análogos del Tipifarnib con Actividad Antichagásica
por: Granados-Tavera,Kevin, et al.
Publicado: (2019) -
Relative Contributions of Prenylation and Postprenylation Processing in <named-content content-type="genus-species">Cryptococcus neoformans</named-content> Pathogenesis
por: Shannon K. Esher, et al.
Publicado: (2016) -
Potential of Farnesyl Transferase Inhibitors in Combination Regimens in Squamous Cell Carcinomas
por: Linda Kessler, et al.
Publicado: (2021) -
Antimicrobial susceptibility and molecular species identification of clinical carbapenem-resistant bacteria
por: MAULIN INGGRAINI, et al.
Publicado: (2021) -
Prevalence and antimicrobial profile of potentially pathogenic bacteria isolated from abattoir effluents in Bulawayo, Zimbabwe
por: Claudious Gufe, et al.
Publicado: (2021)